Placebo News and Research

RSS

Modafinil effective treatment for excessive sleepiness

A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that modafinil is well-tolerated in the treatment of excessive sleepiness associated with disorders of sleep and wakefulness such as shift work sleep disorder, obstructive sleep apnea (OSA) and narcolepsy, and does not affect cardiovascular or sleep parameters.

16 Oct 2007

Study evaluates safety, efficacy and tolerability of probiotics for irritable bowel syndrome

A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis, Bifidobacterium infantis 35624, the sole ingredient in Align (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

16 Oct 2007

Once-a-day epilepsy drug lamotrigine effective for partial seizures

The epilepsy drug lamotrigine is effective in controlling partial seizures when taken once a day as an added therapy, according to a study published in the October 16, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Oct 2007

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

16 Oct 2007

Depression among patients with coronary artery disease

Depression has long had a popular link to cardiovascular disease and death. However, only during the last 15 years scientific evidence supporting this common wisdom has been available (Glassman et al., 2007a).

16 Oct 2007

Hooked on chocolate? the answer why may lie in your gut

For the first time, scientists have linked the all-too-human preference for a food - chocolate - to a specific, chemical signature that may be programmed into the metabolic system and is detectable by laboratory tests.

15 Oct 2007

Pregabalin decreases pain after knee replacement surgery

The drug pregabalin, administered before and after knee replacement surgery, significantly decreased patient pain while increasing and expediting mobility after surgery, according to a new study.

15 Oct 2007

Nicotine patch for prostate surgery relief?

The use of a nicotine patch - successfully used to help many smokers decrease their dependency on nicotine - was shown to reduce pain in men after prostate removal surgery in a new anesthesiology study.

15 Oct 2007

Chili peppers and pain relief

Purified capsaicin, a drug derived from chili peppers, reduced pain for at least three days following groin hernia surgery, according to a new study.

15 Oct 2007

Scientists identify brain circuits that 'decide' how much we eat

Scientists have identified the brain circuits that 'decide' how much we eat. Using live brain scanning techniques and an innovative study design, researchers have discovered how the brain controls food intake in humans. Their findings are published in Nature.

15 Oct 2007

Statins cut heart attacks by more than a quarter

A study into the use of cholesterol-lowering drugs has found they reduce heart attacks by more than 25 per cent.

12 Oct 2007

Benefits of statin drugs continue for years

Scientists in the UK have found that the benefits to the heart from taking statin drugs may last for years and are sustained even after the drugs are stopped.

11 Oct 2007

The highs and lows of drug cravings

The anticipation of a cocaine fix and the actual craving to abuse the drug are two closely related phenomena, according to new evidence published in the online open access journal Substance Abuse Treatment, Prevention, and Policy.

11 Oct 2007

Trial of repeated antibiotic therapy for Lyme diseases

Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.

10 Oct 2007